11-08 :: August 2011
nanotimes
Companies Facts
net income attributable to Cabot Corporation was $62 million ($0.95 per diluted common share) which includes a $0.09 per share charge principally for re- structuring costs. Adjusted EPS was $1.04 per share.
Cabot Corp. has launched “Lumira™ aerogel” as the new brand name for its insulated daylighting systems. Previously, Cabot’s aerogel products were called Nanogel®
in several different market sectors – from building and industrial coatings to energy pipelines and even insulated apparel. Cabot’s rebranding strategy will give the products separate identities and new names for each different market sector
http://www.cabotaerogel.com M
icroscopy business group of Carl Zeiss has granted a sublicense for patents relating to
LED fluorescence excitation in microscopy to Prior Scientific Ltd., Cambridge, UK. These patents protect the use of light emitting diodes for the excitation of fluorescence radiation in light microscopes.
The property rights, which are valid in the USA and Canada, were acquired by Carl Zeiss in 2005. Carl Zeiss uses this technology in a number of products such as iLED-module, Axio Scope FL and Colibri.2 for a wide range of applications extending from routine to high-end microscopy. The users benefit from the optimum flexibility and maximum specimen protec- tion offered by the LEDs as light sources for fluore- scence excitation.
http://www.zeiss.de C aerogel, a name used for all its applications
http://www.chinameditech.com http://www.leica-microsystems.com
C
VD Equipment Corporation (NASADQ: CVV) announced record revenue, income and back-
log. Revenue for the three and six months ended June 30, 2011 was $7,508,000 and $13,713,000 respectively, an increase of 122.1% and 93.1% over the $3,381,000 and $7,103,000 revenue achieved during the three and six months ended June 30, 2010. Income from operations for the three and six months ended June 30, 2011 was $1,202,000 and $2,079,000 as compared to income of $126,000 and $73,000 respectively for the three and six months ended June 30, 2010.
Net Income of $778,000 for the three months ended June 30, 2011 resulted in earnings of $0.15 per sha- re, basic and $0.14 per share diluted as compared with net income of $104,000 or $0.02 per share, ba- sic and diluted for the three months ended June 30, 2010. Net income of $1,466,000 for the six months ended June 30, 2011 resulted in earnings of $0.29 per share, basic and $0.28 per share diluted com- pared to a net loss of ($30,000) or ($0.00) per share basic and diluted for the six months ended June 30,
hina Medical Technologies, Inc. (NASDAQ: CMED), and Leica Biosystems, a division of
Leica Microsystems, have established a sales, re- search and development collaboration to co-develop and market automated FISH kits to be used on the Leica BOND system. CMED will sell the automated FISH kits in China and Leica will have an option to sell the automated FISH kits in the rest of the world.
23
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103